The Market Reports

Index

1 Anti-PCSK9 Monoclonal Antibody Market Overview
1.1 Product Overview and Scope of Anti-PCSK9 Monoclonal Antibody
1.2 Anti-PCSK9 Monoclonal Antibody Segment by Type
1.2.1 Global Anti-PCSK9 Monoclonal Antibody Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Alizumab
1.2.3 Evolocumab
1.3 Anti-PCSK9 Monoclonal Antibody Segment by Application
1.3.1 Anti-PCSK9 Monoclonal Antibody Sales Comparison by Application: (2021-2027)
1.3.2 Hypercholesterolemia
1.3.3 Atherosclerotic Cardiovascular Disease
1.3.4 Others
1.4 Global Anti-PCSK9 Monoclonal Antibody Market Size Estimates and Forecasts
1.4.1 Global Anti-PCSK9 Monoclonal Antibody Revenue 2016-2027
1.4.2 Global Anti-PCSK9 Monoclonal Antibody Sales 2016-2027
1.4.3 Anti-PCSK9 Monoclonal Antibody Market Size by Region: 2016 Versus 2021 Versus 2027

2 Anti-PCSK9 Monoclonal Antibody Market Competition by Manufacturers
2.1 Global Anti-PCSK9 Monoclonal Antibody Sales Market Share by Manufacturers (2016-2021)
2.2 Global Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Anti-PCSK9 Monoclonal Antibody Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Anti-PCSK9 Monoclonal Antibody Manufacturing Sites, Area Served, Product Type
2.5 Anti-PCSK9 Monoclonal Antibody Market Competitive Situation and Trends
2.5.1 Anti-PCSK9 Monoclonal Antibody Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-PCSK9 Monoclonal Antibody Players Market Share by Revenue
2.5.3 Global Anti-PCSK9 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Anti-PCSK9 Monoclonal Antibody Retrospective Market Scenario by Region
3.1 Global Anti-PCSK9 Monoclonal Antibody Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Anti-PCSK9 Monoclonal Antibody Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Anti-PCSK9 Monoclonal Antibody Market Facts & Figures by Country
3.3.1 North America Anti-PCSK9 Monoclonal Antibody Sales by Country
3.3.2 North America Anti-PCSK9 Monoclonal Antibody Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-PCSK9 Monoclonal Antibody Market Facts & Figures by Country
3.4.1 Europe Anti-PCSK9 Monoclonal Antibody Sales by Country
3.4.2 Europe Anti-PCSK9 Monoclonal Antibody Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-PCSK9 Monoclonal Antibody Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-PCSK9 Monoclonal Antibody Sales by Region
3.5.2 Asia Pacific Anti-PCSK9 Monoclonal Antibody Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-PCSK9 Monoclonal Antibody Market Facts & Figures by Country
3.6.1 Latin America Anti-PCSK9 Monoclonal Antibody Sales by Country
3.6.2 Latin America Anti-PCSK9 Monoclonal Antibody Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-PCSK9 Monoclonal Antibody Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-PCSK9 Monoclonal Antibody Sales by Country
3.7.2 Middle East and Africa Anti-PCSK9 Monoclonal Antibody Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Anti-PCSK9 Monoclonal Antibody Historic Market Analysis by Type
4.1 Global Anti-PCSK9 Monoclonal Antibody Sales Market Share by Type (2016-2021)
4.2 Global Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Type (2016-2021)
4.3 Global Anti-PCSK9 Monoclonal Antibody Price by Type (2016-2021)

5 Global Anti-PCSK9 Monoclonal Antibody Historic Market Analysis by Application
5.1 Global Anti-PCSK9 Monoclonal Antibody Sales Market Share by Application (2016-2021)
5.2 Global Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Application (2016-2021)
5.3 Global Anti-PCSK9 Monoclonal Antibody Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Sanofi + Regeneron
6.1.1 Sanofi + Regeneron Corporation Information
6.1.2 Sanofi + Regeneron Description and Business Overview
6.1.3 Sanofi + Regeneron Anti-PCSK9 Monoclonal Antibody Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi + Regeneron Product Portfolio
6.1.5 Sanofi + Regeneron Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Anti-PCSK9 Monoclonal Antibody Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Amgen Product Portfolio
6.2.5 Amgen Recent Developments/Updates

7 Anti-PCSK9 Monoclonal Antibody Manufacturing Cost Analysis
7.1 Anti-PCSK9 Monoclonal Antibody Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-PCSK9 Monoclonal Antibody
7.4 Anti-PCSK9 Monoclonal Antibody Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-PCSK9 Monoclonal Antibody Distributors List
8.3 Anti-PCSK9 Monoclonal Antibody Customers

9 Anti-PCSK9 Monoclonal Antibody Market Dynamics
9.1 Anti-PCSK9 Monoclonal Antibody Industry Trends
9.2 Anti-PCSK9 Monoclonal Antibody Growth Drivers
9.3 Anti-PCSK9 Monoclonal Antibody Market Challenges
9.4 Anti-PCSK9 Monoclonal Antibody Market Restraints

10 Global Market Forecast
10.1 Anti-PCSK9 Monoclonal Antibody Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-PCSK9 Monoclonal Antibody by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Anti-PCSK9 Monoclonal Antibody by Type (2022-2027)
10.2 Anti-PCSK9 Monoclonal Antibody Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-PCSK9 Monoclonal Antibody by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Anti-PCSK9 Monoclonal Antibody by Application (2022-2027)
10.3 Anti-PCSK9 Monoclonal Antibody Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-PCSK9 Monoclonal Antibody by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Anti-PCSK9 Monoclonal Antibody by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Anti-PCSK9 Monoclonal Antibody Sales (KG) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Anti-PCSK9 Monoclonal Antibody Sales (KG) Comparison by Application (2021-2027)
Table 3. Global Anti-PCSK9 Monoclonal Antibody Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Anti-PCSK9 Monoclonal Antibody Covered in This Study
Table 5. Global Anti-PCSK9 Monoclonal Antibody Sales (KG) of Key Manufacturers (2016-2021)
Table 6. Global Anti-PCSK9 Monoclonal Antibody Sales Share by Manufacturers (2016-2021)
Table 7. Global Anti-PCSK9 Monoclonal Antibody Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Anti-PCSK9 Monoclonal Antibody Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Anti-PCSK9 Monoclonal Antibody Average Price (USD/KG) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Anti-PCSK9 Monoclonal Antibody Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-PCSK9 Monoclonal Antibody Product Type
Table 12. Global Anti-PCSK9 Monoclonal Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-PCSK9 Monoclonal Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-PCSK9 Monoclonal Antibody as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-PCSK9 Monoclonal Antibody Sales by Region (2016-2021) & (KG)
Table 16. Global Anti-PCSK9 Monoclonal Antibody Sales Market Share by Region (2016-2021)
Table 17. Global Anti-PCSK9 Monoclonal Antibody Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Anti-PCSK9 Monoclonal Antibody Sales by Country (2016-2021) & (KG)
Table 19. North America Anti-PCSK9 Monoclonal Antibody Sales Market Share by Country (2016-2021)
Table 20. North America Anti-PCSK9 Monoclonal Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Country (2016-2021)
Table 22. Europe Anti-PCSK9 Monoclonal Antibody Sales by Country (2016-2021) & (KG)
Table 23. Europe Anti-PCSK9 Monoclonal Antibody Sales Market Share by Country (2016-2021)
Table 24. Europe Anti-PCSK9 Monoclonal Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Anti-PCSK9 Monoclonal Antibody Sales by Region (2016-2021) & (KG)
Table 27. Asia Pacific Anti-PCSK9 Monoclonal Antibody Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Anti-PCSK9 Monoclonal Antibody Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Region (2016-2021)
Table 30. Latin America Anti-PCSK9 Monoclonal Antibody Sales by Country (2016-2021) & (KG)
Table 31. Latin America Anti-PCSK9 Monoclonal Antibody Sales Market Share by Country (2016-2021)
Table 32. Latin America Anti-PCSK9 Monoclonal Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Anti-PCSK9 Monoclonal Antibody Sales by Country (2016-2021) & (KG)
Table 35. Middle East and Africa Anti-PCSK9 Monoclonal Antibody Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Anti-PCSK9 Monoclonal Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Country (2016-2021)
Table 38. Global Anti-PCSK9 Monoclonal Antibody Sales (KG) by Type (2016-2021)
Table 39. Global Anti-PCSK9 Monoclonal Antibody Sales Market Share by Type (2016-2021)
Table 40. Global Anti-PCSK9 Monoclonal Antibody Revenue (Million US$) by Type (2016-2021)
Table 41. Global Anti-PCSK9 Monoclonal Antibody Revenue Share by Type (2016-2021)
Table 42. Global Anti-PCSK9 Monoclonal Antibody Price (USD/KG) by Type (2016-2021)
Table 43. Global Anti-PCSK9 Monoclonal Antibody Sales (KG) by Application (2016-2021)
Table 44. Global Anti-PCSK9 Monoclonal Antibody Sales Market Share by Application (2016-2021)
Table 45. Global Anti-PCSK9 Monoclonal Antibody Revenue (Million US$) by Application (2016-2021)
Table 46. Global Anti-PCSK9 Monoclonal Antibody Revenue Share by Application (2016-2021)
Table 47. Global Anti-PCSK9 Monoclonal Antibody Price (USD/KG) by Application (2016-2021)
Table 48. Sanofi + Regeneron Corporation Information
Table 49. Sanofi + Regeneron Description and Business Overview
Table 50. Sanofi + Regeneron Anti-PCSK9 Monoclonal Antibody Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 51. Sanofi + Regeneron Anti-PCSK9 Monoclonal Antibody Product
Table 52. Sanofi + Regeneron Recent Developments/Updates
Table 53. Amgen Corporation Information
Table 54. Amgen Description and Business Overview
Table 55. Amgen Anti-PCSK9 Monoclonal Antibody Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 56. Amgen Anti-PCSK9 Monoclonal Antibody Product
Table 57. Amgen Recent Developments/Updates
Table 58. Production Base and Market Concentration Rate of Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Anti-PCSK9 Monoclonal Antibody Distributors List
Table 61. Anti-PCSK9 Monoclonal Antibody Customers List
Table 62. Anti-PCSK9 Monoclonal Antibody Market Trends
Table 63. Anti-PCSK9 Monoclonal Antibody Growth Drivers
Table 64. Anti-PCSK9 Monoclonal Antibody Market Restraints
Table 65. Global Anti-PCSK9 Monoclonal Antibody Sales Forecast by Type (2022-2027) & (KG)
Table 66. Global Anti-PCSK9 Monoclonal Antibody Sales Market Share Forecast by Type (2022-2027)
Table 67. Global Anti-PCSK9 Monoclonal Antibody Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 68. Global Anti-PCSK9 Monoclonal Antibody Revenue Market Share Forecast by Type (2022-2027)
Table 69. Global Anti-PCSK9 Monoclonal Antibody Sales Forecast by Application (2022-2027) & (KG)
Table 70. Global Anti-PCSK9 Monoclonal Antibody Sales Market Share Forecast by Application (2022-2027)
Table 71. Global Anti-PCSK9 Monoclonal Antibody Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 72. Global Anti-PCSK9 Monoclonal Antibody Revenue Market Share Forecast by Application (2022-2027)
Table 73. Global Anti-PCSK9 Monoclonal Antibody Sales Forecast by Region (2022-2027) & (KG)
Table 74. Global Anti-PCSK9 Monoclonal Antibody Sales Market Share Forecast by Region (2022-2027)
Table 75. Global Anti-PCSK9 Monoclonal Antibody Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 76. Global Anti-PCSK9 Monoclonal Antibody Revenue Market Share Forecast by Region (2022-2027)
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-PCSK9 Monoclonal Antibody
Figure 2. Global Anti-PCSK9 Monoclonal Antibody Market Share by Type in 2020 & 2027
Figure 3. Alizumab Product Picture
Figure 4. Evolocumab Product Picture
Figure 5. Global Anti-PCSK9 Monoclonal Antibody Market Share by Application in 2020 & 2027
Figure 6. Hypercholesterolemia
Figure 7. Atherosclerotic Cardiovascular Disease
Figure 8. Others
Figure 9. Global Anti-PCSK9 Monoclonal Antibody Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Anti-PCSK9 Monoclonal Antibody Market Size 2016-2027 (US$ Million)
Figure 11. Global Anti-PCSK9 Monoclonal Antibody Sales 2016-2027 (KG)
Figure 12. Global Anti-PCSK9 Monoclonal Antibody Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Anti-PCSK9 Monoclonal Antibody Sales Share by Manufacturers in 2020
Figure 14. Global Anti-PCSK9 Monoclonal Antibody Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Anti-PCSK9 Monoclonal Antibody Players: Market Share by Revenue in 2020
Figure 16. Anti-PCSK9 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Anti-PCSK9 Monoclonal Antibody Sales Market Share by Region (2016-2021)
Figure 18. Global Anti-PCSK9 Monoclonal Antibody Sales Market Share by Region in 2020
Figure 19. Global Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Region (2016-2021)
Figure 20. Global Anti-PCSK9 Monoclonal Antibody Revenue Market Share by Region in 2020
Figure 21. U.S. Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Anti-PCSK9 Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Anti-PCSK9 Monoclonal Antibody by Type (2016-2021)
Figure 46. Sales Market Share of Anti-PCSK9 Monoclonal Antibody by Application (2016-2021)
Figure 47. Sales Market Share of Anti-PCSK9 Monoclonal Antibody by Application in 2020
Figure 48. Revenue Share of Anti-PCSK9 Monoclonal Antibody by Application (2016-2021)
Figure 49. Revenue Share of Anti-PCSK9 Monoclonal Antibody by Application in 2020
Figure 50. Manufacturing Cost Structure of Anti-PCSK9 Monoclonal Antibody
Figure 51. Manufacturing Process Analysis of Anti-PCSK9 Monoclonal Antibody
Figure 52. Anti-PCSK9 Monoclonal Antibody Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed